Home LiteratureArticle Details
PMID: 25328665 Published · epublish English Journal Article

Absence of Appl2 sensitizes endotoxin shock through activation of PI3K/Akt pathway.

Cell & bioscience ·Vol. 4 ·No. 1 ·2014-00-00 ·页码 60

Mao L, Lin W, Nie T, Hui X, Gao X, Li K, Ding M, Tang X, Li P, Wang Y, Xu A, Liu P, Wu D

Abstract

The adapter proteins Appl1 (adaptor protein containing pleckstrin homology domain, phosphotyrosine domain, and leucine zipper motif 1) and Appl2 are highly homologous and involved in several signaling pathways. While previous studies have shown that Appl1 plays a pivotal role in adiponectin signaling and insulin secretion, the physiological functions of Appl2 are largely unknown. In the present study, the role of Appl2 in sepsis shock was investigated by using Appl2 knockout (KO) mice. When challenged with lipopolysaccharides (LPS), Appl2 KO mice exhibited more severe symptoms of endotoxin shock, accompanied by increased production of proinflammatory cytokines. In comparison with the wild-type control, deletion of Appl2 led to higher levels of TNF-α and IL-1β in primary macrophages. In addition, phosphorylation of Akt and its downstream effector NF-κB was significantly enhanced. By co-immunoprecipitation, we found that Appl2 and Appl1 interacted with each other and formed a complex with PI3K regulatory subunit p85α, which is an upstream regulator of Akt. Consistent with these results, deletion of Appl1 in macrophages exhibited characteristics of reduced Akt activation and decreased the production of TNFα and IL-1β when challenged by LPS. Results of the present study demonstrated that Appl2 is a critical negative regulator of innate immune response via inhibition of PI3K/Akt/NF-κB signaling pathway by forming a complex with Appl1 and PI3K.

Keywords
Akt Appl1 Appl2 Endotoxin shock Inflammatory cytokines NF-κB PI3K
作者与单位
共 13 位作者,点击展开单位 / ORCID
Mao Liufeng
Key Laboratory of Regenerative Biology, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530 China.
Lin Wanhua
School of Life Sciences, Guangxi Normal University, Guilin, 541004 China ; Lab for Stem Cell and Pharmaceutical Biotechnology of Guangxi Normal University, Guilin, 541004 China.
Nie Tao
Key Laboratory of Regenerative Biology, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530 China.
Hui Xiaoyan
State key laboratory of pharmaceutical biotechnology, Department of Medicine, The University of Hong Kong, Hong Kong, 999077 China.
Gao Xuefei
Wellcome Trust Sanger Institute, Cambridge, CB10 1SA UK.
Li Kuai
Key Laboratory of Regenerative Biology, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530 China.
Ding Mengxiao
Key Laboratory of Regenerative Biology, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530 China.
Tang Xiaofeng
Key Laboratory of Regenerative Biology, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530 China.
Li Peng
Key Laboratory of Regenerative Biology, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530 China.
Wang Yu
State key laboratory of pharmaceutical biotechnology, Department of Medicine, The University of Hong Kong, Hong Kong, 999077 China.
Xu Aimin
State key laboratory of pharmaceutical biotechnology, Department of Medicine, The University of Hong Kong, Hong Kong, 999077 China.
Liu Pentao
Wellcome Trust Sanger Institute, Cambridge, CB10 1SA UK.
Wu Donghai
Key Laboratory of Regenerative Biology, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530 China.
Article Info
Journal
Cell & bioscience
Abbr.
Cell Biosci
ISSN
2045-3701
Published
2014-00-00
电子出版
2014-00-02
页码
60
Language
English
Country/Region
England
NLM ID
101561195
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com